Farfield buys Thermo Electron’s biosensor business
Farfield Group completed the acquisition of the resonant mirror optical biosensor business (formally known as Affinity Sensors) and related assets from Thermo Electron (Waltham, MA) for an undisclosed sum.
CREWE, UK - Farfield Group completed the acquisition of the resonant mirror optical biosensor business (formally known as Affinity Sensors) and related assets from Thermo Electron (Waltham, MA) for an undisclosed sum. According to Farfield, the acquisition will increase its life science market penetration and is in line with Farfield Group’s strategy of providing a comprehensive range of products and services allied to its core patented dual waveguide interferometer technology, including measurement tools for the characterization of protein structure and function.
Farfield Group has contracted with Thermo Electron to undertake the manufacture and supply of cuvette consumables and provide continued service delivery to the existing Affinity Sensor IAsys instrument worldwide customer base. The supply of the resonant mirror products will be undertaken by a new subsidiary, NeoSensors Ltd., which will also supply all the Group’s consumable products.
The acquisition also gives the Farfield Group the opportunity to introduce existing Affinity Sensor IAsys instrument users to the next generation of optical biosensors through the AnaLight DPI product range. Customers to be targeted cover a wide range from household names in pharmaceutical and biotechnology industries through to leading academic research facilities.